Skip to main content

Cardiometabolic Disease Group publishes review on heart failure models

Posted 8th September, 2021

The Cardiometabolic Disease Group at HRI has published a much-needed review on models of heart failure with preserved ejection fraction (HFpEF).

HFpEF is the most common type of heart failure in the world, with a huge impact on mortality. There are currently no effective treatments for HFpEF. Patients diagnosed with HFpEF have a 2.1 year median survival rate, and 75 per cent die within five years of diagnosis.

“This type of heart failure represents the greatest unmet need in cardiovascular medicine,” says group leader and cardiologist Dr John O’Sullivan.

Image: Dr John O'Sullivan, Cardiometabolic Disease Group Leader

Related research areas

Donate today

Breaking ground. Healing hearts.

Every donation to HRI supports world-class research that will give people affected by cardiovascular disease more time with the ones they love.

Other ways to give